CDH1 and breast carcinoma: For the E-cad marker, significant differences were observed between hereditary breast cancer patients and non-hereditary breast cancer patients (P < 0.005), between CHBC patients and non-hereditary breast cancer patients (P < 0.005), and also between NCHBC patients and non-hereditary breast cancer patients (P < 0.05).